XML 48 R38.htm IDEA: XBRL DOCUMENT v3.22.4
SCHEDULE OF CASH AND CASH EQUIVALENTS AND INVESTMENTS (Details) - USD ($)
6 Months Ended 12 Months Ended
Dec. 31, 2022
Jun. 30, 2022
Dec. 31, 2021
Impairment Effects on Earnings Per Share [Line Items]      
Cash and Cash Equivalents $ 7,204,722 $ 16,249,666 $ 24,828,043
Cash [Member]      
Impairment Effects on Earnings Per Share [Line Items]      
Cost 611,626 1,233,608  
Cash and Cash Equivalents 611,626 1,233,608  
Money Market Funds [Member] | Fair Value, Inputs, Level 1 [Member]      
Impairment Effects on Earnings Per Share [Line Items]      
Cost 6,593,096 15,016,058  
Cash and Cash Equivalents 6,593,096 15,016,058  
Fair Value 6,593,096 15,016,058  
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 1 [Member]      
Impairment Effects on Earnings Per Share [Line Items]      
Cost 7,204,722 16,249,666  
Cash and Cash Equivalents 7,204,722 16,249,666  
Fair Value 6,593,096 15,016,058  
Investments [Member] | Fair Value, Inputs, Level 1 [Member]      
Impairment Effects on Earnings Per Share [Line Items]      
Cost 241,595 245,187  
Fair Value 236,576 239,314  
Unrealized Gain (Loss) (5,019) (5,873)  
Investments $ 236,576 $ 239,314